Planeeria Company
Planeeria focuses on developing a product based on recombinant human amelogenin as an active ingredient for the treatment of injured cartilage and ligaments. The company develops innovative products for regeneration and recovery after injuries.
Technology:
Specific disorder-related
Industry:
Treatment range
Headquarters:
Lod, Israel
Founded Date:
01.05.2018
Employees Number:
N/A
Funding Status:
N/A
Total Funding:
$0
Estimated Revenue:
$0
Last Funding Date:
N/A
Last Funding Type:
N/A
Register and Claim Ownership